Dr. Nafees Malik, MBChB, MPhil
Head of Cell & Gene Therapy, Juvenescence
Great medical advances in the coming years and decades can be expected from the power to control and manipulate cells. Cellular therapies offer the potential for true regeneration, replacement and cure. Juvenescence is serious about being a leader in this area as applied to aging.
Dr. Nafees Malik, MBChB, MPhil is the Head of JuvRegeneration at Juvenescence and also the Chief Operating Officer of Juvenescence’s partner AgeX Therapeutics, Inc.
“I am impressed by the founders of Juvenescence and their vision and passion for the longevity space,” he says, “I am inspired to be a part of this team.”
Dr. Malik has an almost 20-year career, with roles spanning clinical medicine, healthcare investment banking, biopharma industry, and research and academic institutions. He was the Founder and CEO of Asklepian Consulting, a boutique consultancy focused on the strategic and commercial analysis of cell and gene therapies and regenerative medicines. Dr. Malik previously held positions in healthcare M&A at Barclays Capital and in pharma equity research at Panmure Gordon. He has also worked with world-leading biopharma companies, including GSK, Pfizer Regenerative Medicine, and the Cell and Gene Therapy Catapult.
Dr. Malik has significant thought leadership experience as lead author of several book chapters on regenerative medicine and four published industry-leading frameworks on the commercialization of cell and gene therapies. He is first author on more than 20 publications, including in Nature, Nature Biotechnology, Nature Reviews Clinical Oncology, and Lancet.
Dr. Malik has a medical degree from the University of Liverpool and an MPhil in Bioscience Enterprise from Cambridge University. He is an honorary lecturer in bioscience enterprise and strategy at the Institute of Biotechnology at Cambridge University.
Dr. Malik has a passion for reading, philosophy, astronomy and long walks; his frequent fitness choice.